Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Дифференцированная вторичная профилактика инсульта: дополнение к рекомендациям
Дифференцированная вторичная профилактика инсульта: дополнение к рекомендациям
Л.В.Стаховская, К.С.Мешкова, К.В.Шеховцова, В.И.Скворцова. Дифференцированная вторичная профилактика инсульта: дополнение к рекомендациям. Consilium Medicum. Неврология (Прил.). 2009; 1: 16-18.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Adams RJ, Albers G, Alberts MJ et al. Update to the AHA/ASA Recommendations for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. Stroke 2008; 39: 1647–52.
2. Sacco RL, Adams R, Albers G et al. American Heart Association; American Stroke Аssociation Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co_sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37: 577–617.
3. Bhatt DL, Fox KA, Hacke W et al. CHARISMA Investigators.Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354 (16): 1706–17.
4. Pfeffer M.A., Jarcho J.A. The charisma of subgroups and the subgroups of CHARISMA. N Engl J Med 2006; 354: 1744–6.
5. Diener HC, Bogousslavsky J, Brass LM et al. MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high risk patients (MATCH): randomised, double blind, placebo controlled trial. Lancet 2004; 364: 331–7.
6. Halkes PH, van Gijn J, Kappelle LJ et al. ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367 (9523): 1665–73.
7. Verro P, Gorelick PB, Nguyen D. Aspirin Plus Dipyridamole Versus Aspirin for Prevention of Vascular Events After Stroke or TIA. A Meta Analysis. Stroke 2008; 39: 1358.
8. Amarenco P, Bogousslavsky J, Callahan A III et al. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549–59.
9. European Stroke Prevention Study (ESPS): antithrombotic therapy is also effective in the elderly. Department of Neurology, University of Kuopio, Finland. Acta Neurol Scand 1993; 87 (2): 111–411.
10. Скворцова В.И., Стаховская Л.В., Пряникова Н.А. и др. Как правильно выбрать антиагрегант для вторичной профилактики ишемического инсульта. Справочник поликлинич. врача. 2007; 6: 54–8.
11. Скворцова В.И., Стаховская Л.В., Пряникова Н.А. и др. Вторичная профилактика инсульта. Consilium Medicum 2006; 8: 70–3.
2. Sacco RL, Adams R, Albers G et al. American Heart Association; American Stroke Аssociation Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co_sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37: 577–617.
3. Bhatt DL, Fox KA, Hacke W et al. CHARISMA Investigators.Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354 (16): 1706–17.
4. Pfeffer M.A., Jarcho J.A. The charisma of subgroups and the subgroups of CHARISMA. N Engl J Med 2006; 354: 1744–6.
5. Diener HC, Bogousslavsky J, Brass LM et al. MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high risk patients (MATCH): randomised, double blind, placebo controlled trial. Lancet 2004; 364: 331–7.
6. Halkes PH, van Gijn J, Kappelle LJ et al. ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367 (9523): 1665–73.
7. Verro P, Gorelick PB, Nguyen D. Aspirin Plus Dipyridamole Versus Aspirin for Prevention of Vascular Events After Stroke or TIA. A Meta Analysis. Stroke 2008; 39: 1358.
8. Amarenco P, Bogousslavsky J, Callahan A III et al. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549–59.
9. European Stroke Prevention Study (ESPS): antithrombotic therapy is also effective in the elderly. Department of Neurology, University of Kuopio, Finland. Acta Neurol Scand 1993; 87 (2): 111–411.
10. Скворцова В.И., Стаховская Л.В., Пряникова Н.А. и др. Как правильно выбрать антиагрегант для вторичной профилактики ишемического инсульта. Справочник поликлинич. врача. 2007; 6: 54–8.
11. Скворцова В.И., Стаховская Л.В., Пряникова Н.А. и др. Вторичная профилактика инсульта. Consilium Medicum 2006; 8: 70–3.
Авторы
Л.В.Стаховская, К.С.Мешкова, К.В.Шеховцова, В.И.Скворцова
Научно-исследовательский институт инсульта РГМУ, Москва
Научно-исследовательский институт инсульта РГМУ, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.